Skip to content

Prostate biopsy complications

What to expect, how the two routes differ, how each complication is treated and when to get in touch.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 16, 2026
Book a consultation
Drawing of the pelvis from the side with the needle entering through the perineum to the prostate, a bruise and a dashed circle around the area that needs attention
On this page

Quick answer

Most complications of a prostate biopsy are mild and settle on their own. Blood in the urine and semen happens in almost all men.1 The big difference between the two routes is infection: in a review cited by the European guideline, sepsis, an infection that reaches the bloodstream, occurred in about 0.1% after a transperineal biopsy and 0.9% after a transrectal one.2 A fever, chills, being unable to pass urine or blood with clots that does not improve call for contact the same day.

The two routes side by side

In the transperineal route, the needle goes in through the skin of the perineum. In the transrectal route, it passes through the wall of the rectum. The transperineal biopsy page explains the test, and choosing the route is covered in transperineal or transrectal.

ComplicationTransperinealTransrectal
SepsisAbout 0.1%About 0.9%2
Infection needing hospital admissionLess than 1%2%3
Retention needing a catheter6%5%3
Rectal bleeding95% lower riskMore frequent4
Blood in the urineSimilarSimilar4
Pain after the testAbout twice as frequentLess frequent4

The figures for infection needing admission and for retention come from a randomized trial of 1,126 men.3 In a review of five randomized trials with 3,072 men, the transperineal route had less infection, even without antibiotics, and urinary retention did not differ between the routes.5

Blood in the urine, semen and stool

Blood in the urine happens in almost all men and can last up to 10 days, sometimes with small clots. Blood in the semen is just as common. It can last up to six weeks and poses no risk to you or your partner.1 With both routes, this bleeding is usually mild and settles on its own.6

A small amount of blood in the stool, for about two weeks, can also appear.7 Severe rectal bleeding is uncommon.6 With the transperineal route, a review of 20 studies found a 95% lower risk of rectal bleeding than with the transrectal route, although it is not zero.4

Drinking plenty of fluid helps clear the urine. In about 1 in 50 men, clots block the flow of urine, and in about 1 in 100 the bleeding leads to a hospital admission.1 Blood with clots that does not improve calls for contact the same day.

Bruising, pain and urinary retention

In the transperineal route, the needle passes through the skin of the perineum. Bruising and discomfort at that spot happen in 1 in 2 to 1 in 10 men.1 Pain after the test was about twice as frequent as with the transrectal route.4 In a randomized trial, this difference was small and gone by seven days.8 A simple painkiller, such as paracetamol (acetaminophen), is usually enough.7

Some men cannot pass urine after a biopsy. This is called urinary retention and happens in about 1 in 20, according to the British Association of Urological Surgeons leaflet.1 An older review found retention in under 2%, slightly more often after a transperineal template biopsy.6 The treatment is a catheter, which may stay in for a few days, including at home.7 Being unable to pass urine calls for contact the same day.

Infection and sepsis: the big difference between the routes

In the transrectal route, the needle passes through the rectum. Infection is the most common complication of this biopsy, and antibiotic-resistant Escherichia coli, a bowel bacterium, plays a major role. According to an American Urological Association white paper, infection rates range from 0.1% to 7% and sepsis rates from 0.3% to 3.1%, depending on the preventive antibiotics.9

In the transperineal route, the needle does not pass through the rectum. In a review of ten randomized trials with 4,188 biopsies, the risk of hospital admission for infection was 77% lower than with the transrectal route.10 The review cited by the European guideline, with 162,577 men, found sepsis in about 0.1% after a transperineal biopsy and 0.9% after a transrectal one.2

This holds without antibiotics. In a randomized trial of 553 men, none had sepsis or an infection needing admission, with or without antibiotics. Urinary infection without admission occurred in 1.09% of those who did not receive antibiotics and in 0.36% of those who did.11 In the PREVENT trial, no one had an infection with the transperineal route without antibiotics, compared with 1.4% with the transrectal route with antibiotics, a difference that did not reach statistical significance.8 The European guideline recommends skipping antibiotics for a transperineal biopsy in men without risk factors, such as diabetes or a history of urinary retention.2 In the ProBE-PC trial, infection occurred in 2.7% with the transperineal route and 2.6% with the transrectal route, with no cases of sepsis.12

A mild urinary infection, which happens in about 1 in 100 men, is treated with antibiotics.1 Sepsis needs hospital admission, with intravenous antibiotics.1,9

Erections and urinary symptoms

Temporary erection problems, caused by bruising, happen in about 1 in 20 men.1 In a review, erections returned to baseline within 1 to 6 months.13 In a randomized trial, sexual function four months later was similar between the two routes.3

Up to 25% of men have temporary urinary symptoms after a biopsy, such as needing to pass urine more often or a weaker stream, and they usually need no treatment.6 In the same randomized trial, urinary symptom scores four months later were the same for both routes.3

Reactions to sedation

Sedation has risks too, but serious complications are rare. In a German registry of 368,206 digestive endoscopies, minor complications occurred in 0.3% of sedated patients and major ones in 0.01%. The risk was higher in people with other significant illnesses and varied with the type and length of the procedure.14 That is why I review your health conditions and medications before the biopsy.

Can a biopsy spread cancer?

Needle tract seeding happens when tumor cells are left along the path the needle took. In a 2015 review, the authors found 26 publications reporting 42 cases, most after a transperineal biopsy and 9 after a transrectal one. Based on the series reviewed, the incidence appears to be below 1%, and the rise in the number of biopsies and cores over the years has not increased the reported cases.15

The authors conclude that the benefit of diagnosing and treating the cancer outweighs this risk, and they do not advise avoiding a biopsy because of it.15

How I approach it

I have performed transperineal prostate biopsy since 2022. In my practice, it is done in the operating room, always with sedation, and takes about 20 minutes. With the transperineal route, I do the biopsy without antibiotics. Before the test, I review the medications you take. Blood thinners and aspirin are decided case by case, so do not stop any of them on your own. Preparing for a prostate biopsy covers each step.

Before the biopsy, I explain what to expect in the following days, such as blood in the urine and semen, and what the warning signs are. You go home the same day, with someone to accompany you, and you should not drive that day. The transrectal route is also an option, and we decide together which route suits your case.

I am a co-author of a randomized trial that compared prostate biopsy with 12 and with 20 cores, presented at the American Urological Association annual meeting in 2017. The first consultation and the results consultation can be online, in English.

When to see a urologist

Get in touch the same day if you have:

  • A fever or chills
  • Difficulty passing urine, or being unable to pass it
  • Blood with clots in the urine that does not improve

See a urologist as well if you have been referred for a biopsy and want to understand the risks of each route before deciding.

Frequently asked questions

What are the most common complications of a prostate biopsy?

Blood in the urine, which can last up to 10 days, and blood in the semen, which can last up to six weeks, happen in almost all men. With the transperineal route, bruising in the perineum happens in 1 in 2 to 1 in 10 men.1 This bleeding is usually mild and settles on its own.6

Which biopsy route has a lower risk of infection?

The transperineal route. In a review cited by the European guideline, sepsis occurred in about 0.1% after a transperineal biopsy and 0.9% after a transrectal one.2 In a review of ten randomized trials, the risk of hospital admission for infection was 77% lower with the transperineal route.10

Is it normal to be unable to pass urine after a biopsy?

It can happen in about 1 in 20 men.1 The treatment is a catheter, which may stay in for a few days, including at home.7 If you cannot pass urine, get in touch the same day.

Can a biopsy spread prostate cancer?

It is rare. A 2015 review found 42 cases of tumor cells left along the needle track, reported in 26 publications, with an incidence that appears to be below 1%. The authors conclude that the benefit of diagnosis outweighs this risk and do not advise avoiding a biopsy because of it.15

Can a prostate biopsy cause erectile dysfunction?

Temporary erection problems happen in about 1 in 20 men.1 In a review, erections returned to baseline within 1 to 6 months.13 In a randomized trial, sexual function four months later was similar between the two routes.3

Does the sedation for a biopsy carry risks?

Yes, but serious complications are rare. In a German registry of 368,206 digestive endoscopies, minor complications occurred in 0.3% of sedated patients and major ones in 0.01%. The risk was higher in people with other significant illnesses.14

When should I get in touch after a prostate biopsy?

The same day, if you have a fever, chills, cannot pass urine or have blood with clots in the urine that does not improve.

Who performs transperineal prostate biopsy in São Paulo?

I have performed transperineal prostate biopsy in São Paulo since 2022. I am Dr. Petronio Melo, a urologist and robotic surgeon, CRM-SP 157.598 and RQE 70.275. I hold a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I have performed more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. In my practice, the biopsy is always done with sedation. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. British Association of Urological Surgeons. Transperineal biopsies of the prostate: information about your procedure. Leaflet O24/107; 2024. BAUS
  2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: diagnostic evaluation. European Association of Urology; 2026. EAU
  3. Bryant RJ, Marian IR, Williams R, et al. Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial. Lancet Oncol. 2025;26(5):583-595. PubMed
  4. Du J, Chen S, Terris MK, et al. Comparison of prostate cancer detection rates and complications between transrectal ultrasound-guided transperineal and transrectal biopsies: a systematic review and meta-analysis. Transl Androl Urol. 2025;14(5):1418-1428. PubMed
  5. Marra G, Bazzurro F, Dematteis A, et al. Transperineal Versus Transrectal Biopsy for Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Oncol. 2026. doi:10.1016/j.euo.2026.01.009. PubMed
  6. Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol. 2013;64(6):876-892. PubMed
  7. Prostate Cancer UK. Prostate biopsy. 2025. Prostate Cancer UK
  8. Hu JC, Assel M, Allaf ME, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86(1):61-68. PubMed
  9. Liss MA, Ehdaie B, Loeb S, et al. An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy. J Urol. 2017;198(2):329-334. PubMed
  10. Stangl FP, Day E, Vallée M, et al. Infectious Complications After Transrectal Versus Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis. Eur Urol Focus. 2026;12(2):275-283. PubMed
  11. Jacewicz M, Günzel K, Rud E, et al. Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial. Lancet Infect Dis. 2022;22(10):1465-1471. PubMed
  12. Mian BM, Feustel PJ, Aziz A, et al. Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial. J Urol. 2024;211(2):205-213. PubMed
  13. Borghesi M, Ahmed H, Nam R, et al. Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol. 2017;71(3):353-365. PubMed
  14. Behrens A, Kreuzmayr A, Manner H, et al. Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications. Gut. 2019;68(3):445-452. PubMed
  15. Volanis D, Neal DE, Warren AY, Gnanapragasam VJ. Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literature. BJU Int. 2015;115(5):698-704. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation

Related guides